adenine and palbociclib

adenine has been researched along with palbociclib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sinha, G1
Dagher, R; Donnelly, ET; Kalanovic, D; Koehler, M; Rothenberg, ML1
Bartlett, NL; Blum, KA; Chen, Z; Chen-Kiang, S; DiLiberto, M; Dittus, C; Huang, X; Inghirami, G; Leonard, JP; Maddocks, K; Martin, P; Park, S; Ridling, L; Ruan, J1

Trials

1 trial(s) available for adenine and palbociclib

ArticleYear
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.
    Blood, 2019, 03-14, Volume: 133, Issue:11

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Piperidines; Prognosis; Pyrazoles; Pyridines; Pyrimidines; Survival Rate

2019

Other Studies

2 other study(ies) available for adenine and palbociclib

ArticleYear
Overcoming mantle cell lymphoma's ibrutinib resistance.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:11

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinases; Cysteine; Drug Resistance, Neoplasm; Humans; Lymphoma, Mantle-Cell; Mutation; Piperazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Purines; Pyrazoles; Pyridines; Pyrimidines; Quinazolinones; Serine

2014
Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:7

    Topics: Adenine; Antineoplastic Agents; Drug Evaluation; Humans; Neoplasms; Patient Selection; Piperazines; Piperidines; Pragmatic Clinical Trials as Topic; Pyrazoles; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Research Design

2016